Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis
Copyright © 2020 Elsevier Ltd. All rights reserved..
BACKGROUND: Elevated extracellular DNA levels are found in the sputum of patients with cystic fibrosis (CF). However, studies investigating the association of extracellular DNA with CF severity are scarce.
OBJECTIVE: To evaluate the association of extracellular DNA levels with pulmonary function, antibiotic use, and hospitalization in CF patients.
METHODS: This cross-sectional study included CF patients aged ≥5 years who were clinically stable and produced spontaneously expectorated sputum. Extracellular DNA in sputum was quantified, and extracellular DNA networks were seen with immunofluorescence microscopy. Also, cell death profile was assessed. Data on pulmonary function, airway colonization, antibiotic use, and hospitalization in the previous year were collected. Patients were divided into two groups based on median DNA level.
RESULTS: Thirty-three patients were included. Their mean age was 16.3 ± 6.2 years, mean forced expiratory volume in the first second (FEV1) was 67.0 ± 26.7 (% of the predicted), and mean DNA level was 241.9 ± 147.2 μg/mL. There were significant correlations of DNA level with FEV1 (r = -0.60; p < 0.001) and forced vital capacity (r = -0.59; p < 0.001). Moreover, patients with higher DNA level (>243.0 μg/mL) had lower FEV1 (52.1 ± 27.8% vs. 81.1 ± 16.2%; p = 0.001) and required more hospitalizations (68.8% vs. 35.3%; p = 0.05). Additional findings were the presence of extracellular DNA networks and low rates of necrosis and apoptosis.
CONCLUSION: Elevated extracellular DNA levels in CF sputum are associated with reduced pulmonary function and increased hospitalizations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:172 |
|---|---|
| Enthalten in: |
Respiratory medicine - 172(2020) vom: 01. Okt., Seite 106144 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Piva, Taila Cristina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Airway obstruction |
|---|
| Anmerkungen: |
Date Completed 09.06.2021 Date Revised 09.06.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.rmed.2020.106144 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315090480 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315090480 | ||
| 003 | DE-627 | ||
| 005 | 20231225154146.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rmed.2020.106144 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1050.xml |
| 035 | |a (DE-627)NLM315090480 | ||
| 035 | |a (NLM)32937222 | ||
| 035 | |a (PII)S0954-6111(20)30284-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Piva, Taila Cristina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.06.2021 | ||
| 500 | |a Date Revised 09.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND: Elevated extracellular DNA levels are found in the sputum of patients with cystic fibrosis (CF). However, studies investigating the association of extracellular DNA with CF severity are scarce | ||
| 520 | |a OBJECTIVE: To evaluate the association of extracellular DNA levels with pulmonary function, antibiotic use, and hospitalization in CF patients | ||
| 520 | |a METHODS: This cross-sectional study included CF patients aged ≥5 years who were clinically stable and produced spontaneously expectorated sputum. Extracellular DNA in sputum was quantified, and extracellular DNA networks were seen with immunofluorescence microscopy. Also, cell death profile was assessed. Data on pulmonary function, airway colonization, antibiotic use, and hospitalization in the previous year were collected. Patients were divided into two groups based on median DNA level | ||
| 520 | |a RESULTS: Thirty-three patients were included. Their mean age was 16.3 ± 6.2 years, mean forced expiratory volume in the first second (FEV1) was 67.0 ± 26.7 (% of the predicted), and mean DNA level was 241.9 ± 147.2 μg/mL. There were significant correlations of DNA level with FEV1 (r = -0.60; p < 0.001) and forced vital capacity (r = -0.59; p < 0.001). Moreover, patients with higher DNA level (>243.0 μg/mL) had lower FEV1 (52.1 ± 27.8% vs. 81.1 ± 16.2%; p = 0.001) and required more hospitalizations (68.8% vs. 35.3%; p = 0.05). Additional findings were the presence of extracellular DNA networks and low rates of necrosis and apoptosis | ||
| 520 | |a CONCLUSION: Elevated extracellular DNA levels in CF sputum are associated with reduced pulmonary function and increased hospitalizations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Airway obstruction | |
| 650 | 4 | |a Cystic fibrosis | |
| 650 | 4 | |a Extracellular traps | |
| 650 | 4 | |a Hospitalization | |
| 650 | 4 | |a Sputum | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Luft, Carolina |e verfasserin |4 aut | |
| 700 | 1 | |a Antunes, Krist Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Marostica, Paulo José Cauduro |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto, Leonardo Araújo |e verfasserin |4 aut | |
| 700 | 1 | |a Donadio, Márcio Vinícius Fagundes |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiratory medicine |d 1993 |g 172(2020) vom: 01. Okt., Seite 106144 |w (DE-627)NLM012605247 |x 1532-3064 |7 nnns |
| 773 | 1 | 8 | |g volume:172 |g year:2020 |g day:01 |g month:10 |g pages:106144 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rmed.2020.106144 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 172 |j 2020 |b 01 |c 10 |h 106144 | ||